Addus HomeCare (NASDAQ:ADUS) Stock Moved Up to Strong-Buy by Wall Street Zen

Posted by Stanley Muller on Nov 8th, 2026

Wall Street Zen upgraded shares of Addus HomeCare (NASDAQ:ADUS – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Saturday,Wall Street Zen reports.

A number of other equities analysts have also recently commented on the stock. Royal Bank Of Canada lifted their target price on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. UBS Group upped their price target on shares of Addus HomeCare from $145.00 to $160.00 and gave the company a “buy” rating in a research report on Thursday. Barclays raised their price objective on Addus HomeCare from $96.00 to $101.00 and gave the company an “underweight” rating in a research note on Wednesday. Citigroup downgraded Addus HomeCare from a “market outperform” rating to a “neutral” rating in a report on Monday, September 14th. Finally, TD Cowen increased their target price on Addus HomeCare from $131.00 to $145.00 and gave the company a “buy” rating in a report on Thursday. Seven equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Addus HomeCare presently has an average rating of “Moderate Buy” and an average price target of $134.70.

View Our Latest Research Report on Addus HomeCare

Addus HomeCare Stock Down 2.0%

Shares of NASDAQ ADUS opened at $124.31 on Friday. The stock has a market capitalization of $2.32 billion, a P/E ratio of 20.72, a PEG ratio of 1.65 and a beta of 0.75. Addus HomeCare has a one year low of $87.95 and a one year high of $131.59. The firm’s 50 day simple moving average is $117.60 and its two-hundred day simple moving average is $106.88. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.64 and a quick ratio of 1.69.

Addus HomeCare (NASDAQ:ADUS – Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.79 by $0.04. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The firm had revenue of $387.74 million during the quarter, compared to analyst estimates of $388.72 million. During the same period in the previous year, the business posted $1.56 EPS. The business’s quarterly revenue was up 7.0% on a year-over-year basis. As a group, analysts expect that Addus HomeCare will post 6.34 EPS for the current fiscal year.

Institutional Investors Weigh In On Addus HomeCare

A number of large investors have recently added to or reduced their stakes in ADUS. NFJ Investment Group LLC bought a new position in shares of Addus HomeCare during the second quarter valued at about $29,000. Heritage Family Offices LLP bought a new stake in shares of Addus HomeCare in the third quarter worth about $43,000. Parallel Advisors LLC increased its holdings in Addus HomeCare by 66.3% during the 1st quarter. Parallel Advisors LLC now owns 404 shares of the company’s stock valued at $38,000 after purchasing an additional 161 shares during the period. Nisa Investment Advisors LLC increased its holdings in Addus HomeCare by 16.9% during the 3rd quarter. Nisa Investment Advisors LLC now owns 769 shares of the company’s stock valued at $85,000 after purchasing an additional 111 shares during the period. Finally, State of Wyoming purchased a new position in Addus HomeCare during the 2nd quarter valued at about $79,000. Institutional investors own 95.35% of the company’s stock.

More Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

Positive Sentiment: UBS raised its price target to $160 from $145 and maintained a Buy rating; TD Cowen lifted its target to $145 from $131 and also maintained a Buy rating. UBS price-target report TD Cowen price-target report
Positive Sentiment: ADUS recently reached a 52-week high. Its latest quarterly results included earnings per share of $1.83, ahead of the $1.79 consensus, while revenue increased 7% year over year. Addus hits a 12-month high
Positive Sentiment: The company said it expects to close its AccentCare acquisition in the first quarter of 2027 and anticipates a full-year adjusted EBITDA margin around 13%; the deal may offer a growth opportunity, though execution remains ahead. AccentCare update
Neutral Sentiment: Recent Zacks pieces discuss ADUS’s momentum and value-investing appeal, but the available summaries do not provide specific ratings or new estimates. Zacks momentum article Zacks value article
Negative Sentiment: Quarterly revenue of $387.74 million was slightly below analysts’ $388.72 million estimate, tempering the otherwise positive earnings beat. Q3 earnings call highlights

About Addus HomeCare

(Get Free Report)

Addus HomeCare Inc (NASDAQ: ADUS) provides in-home personal care, hospice and home health services to older adults, people with disabilities and other individuals who need assistance with daily living or medical care. Its services are designed to help clients remain safely and independently in their homes while supporting families and caregivers.

The company’s personal care services include assistance with bathing, dressing, grooming, meal preparation, housekeeping and other activities of daily living.